Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

With AI exploding, Proscia hopes to double user base for its digital pathology platform this year

Proscia
By Author Proscia | June 14, 2023

The Philadelphia Business Journal’s John George provides an update on Proscia, including recent deals and partnerships, following a conversation with CEO David West.

Our website uses cookies. By using this site, you agree to its use of cookies.